Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit
经验性使用阿奇霉素治疗 COVID-19 会影响呼吸道微生物群和抗菌药物耐药组,但无抗炎作用
期刊:
影响因子:
doi:10.21203/rs.3.rs-6875205/v1
Langelier, Charles; Glascock, Abigail; Maguire, Cole; Van Phan, Hoang; Lydon, Emily; Calfee, Carolyn; Corry, David; Kheradmand, Farrah; Baden, Lindsey; Sekaly, Rafick-Pierre; McComsey, Grace; Haddad, Elias; Cairns, Charles; Pulendran, Bali; Fernandez-Sesma, Ana; Simon, Viviana; Metcalf, Jordan; Higuita, Nelson; Messer, William; Davis, Mark; Nadeau, Kari C; Kraft, Monica; Bime, Chris; Schaenman, Joanna; Erle, David; Atkinson, Mark; Ehrlich, Lauren I R; Melamed, Esther; Montgomery, Ruth; Shaw, Albert; Hough, Catherine; Geng, Linda; Hoch, Annmarie; Hafler, David; Augustine, Alison; Becker, Patrice; Peters, Bjoern; Ozonoff, Al; Kim-Schulze, Seunghee; Krammer, Florian; Bosinger, Steven; Eckalbar, Walter; Altman, Matthew; Wilson, Michael; Guan, Leying; Maecker, Holden; Steen, Hanno; Diray-Arce, Joann; Rouphael, Nadine; Kleinstein, Steven; Reed, Elaine; Levy, Ofer; Chu, Victoria